摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Oxo-2-phenoxythiocarbonyl-2,5-dihydro-isoxazole-4-carboxylic acid ethyl ester | 197582-13-1

中文名称
——
中文别名
——
英文名称
5-Oxo-2-phenoxythiocarbonyl-2,5-dihydro-isoxazole-4-carboxylic acid ethyl ester
英文别名
Ethyl 5-oxo-2-phenoxythiocarbonyl-2,5-dihydroisoxazole-4-carboxylate;ethyl 5-oxo-2-phenoxycarbothioyl-1,2-oxazole-4-carboxylate
5-Oxo-2-phenoxythiocarbonyl-2,5-dihydro-isoxazole-4-carboxylic acid ethyl ester化学式
CAS
197582-13-1
化学式
C13H11NO5S
mdl
——
分子量
293.3
InChiKey
IWWCFBIDUWKLQY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    97.2
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    5-Oxo-2-phenoxythiocarbonyl-2,5-dihydro-isoxazole-4-carboxylic acid ethyl ester丙酮 为溶剂, 反应 0.42h, 以65%的产率得到ethyl 2-phenoxy-thiazole-5-carboxylate
    参考文献:
    名称:
    5-氧二氢异恶唑的化学性质。19.部分1 Thesynthesis和光解的N- thioacylisoxazol -5(2H) -酮
    摘要:
    5-氧代二氢异喹嗪与硫酰氯反应,生成N-硫酰异喹嗪-5(2H)-酮,这些化合物在光化学条件下失去二氧化碳,并经历亚胺碳烯的分子内环化反应,形成噻唑。然而,在某些情况下,失去二氧化碳的同时伴随失去硫,生成1,3-噁嗪-6-酮。
    DOI:
    10.1039/a700646b
  • 作为产物:
    参考文献:
    名称:
    5-氧二氢异恶唑的化学性质。19.部分1 Thesynthesis和光解的N- thioacylisoxazol -5(2H) -酮
    摘要:
    5-氧代二氢异喹嗪与硫酰氯反应,生成N-硫酰异喹嗪-5(2H)-酮,这些化合物在光化学条件下失去二氧化碳,并经历亚胺碳烯的分子内环化反应,形成噻唑。然而,在某些情况下,失去二氧化碳的同时伴随失去硫,生成1,3-噁嗪-6-酮。
    DOI:
    10.1039/a700646b
点击查看最新优质反应信息

文献信息

  • The chemistry of 5-oxodihydroisoxazoles. Part 22.1 The synthesis of 1,3-oxazin-6-ones from N-thioacylisoxazol-5(2H )-ones
    作者:David S. Millan、Rolf H. Prager
    DOI:10.1039/a804527e
    日期:——
    N-Thioacylisoxazol-5(2H)-ones, prepared by the reaction of thiocarbonyl chlorides with isoxazol-5(2H)-ones in the presence of base, are reduced by triphenylphosphine to afford 1,3-oxazin-6-ones and triphenylphosphine sulfide. If the thioacylation is carried out with phenyl chlorodithioformate, the thermal rearrangement of the intermediate, to again form the oxazin-6-one and sulfur, is so rapid that the use of the phosphine is not required. The presence of an ethoxycarbonyl group at C-3, or of a bromine atom at C-4 of the isoxazolone results in the formation of thiazoles.
    通过在碱的存在下,用硫代羰基氯与异噁唑-5(2H)-酮反应制备的N-硫代乙酰异噁唑-5(2H)-酮,经三苯基膦还原得到1,3-氧杂嗪-6-酮和三苯基膦硫化物。如果使用苯基二硫代甲酸氯进行硫代乙酰化反应,中间体的热重排反应迅速,再次生成氧杂嗪-6-酮和硫,因此不需要使用膦。异噁唑酮的C-3位存在乙氧羰基或C-4位存在溴原子时,会导致形成噻唑。
  • Novel antifungal agent containing heterocyclic compound
    申请人:Nakamoto Kazutaka
    公开号:US20070105943A1
    公开(公告)日:2007-05-10
    The present invention provides an antifungal agent represented by the formula: [wherein A 1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X 1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A 1 may have 1 to 3 substituents, and E has one or two substituents].
    本发明提供了一种抗真菌剂,其表示为以下式子: [其中A1表示一个3-吡啶基团,可能具有取代基,喹啉基团,可能具有取代基或类似物;X1表示由公式—NH—C(═O)—,由公式—C(═O)—NH—或类似物表示的基团;E表示呋喃基团,噻吩基团,吡咯基团,苯基团,吡啶基团,四唑基团,噻唑基团或吡唑基团;但A1可能具有1到3个取代基,E具有一个或两个取代基。]
  • Novel Antimalarial Agent Containing Heterocyclic Compound
    申请人:Nakamoto Kazutaka
    公开号:US20090227799A1
    公开(公告)日:2009-09-10
    Disclosed is an antimalarial agent containing a compound represented by the formula: [wherein A 1 represents a 3-pyridyl group that may have a substituent, a 6-quinolyl group that may have a substituent, or the like; X 1 represents a group represented by the formula —C(═O)—NH— or the like; E represents a furyl group, a thienyl group or a phenyl group; with the proviso that A 1 may have one to three substituents, and E has one of two substituents] or a salt thereof or hydrates thereof.
    揭示了一种抗疟疾剂,其包含由下式表示的化合物: [其中A1表示一个3-吡啶基团,可以有取代基,一个6-喹啉基团,可以有取代基或类似物;X1表示一个由公式-C(═O)-NH-或类似物表示的基团;E表示一个呋喃基团,噻吩基团或苯基团;但前提是A1可以有1到3个取代基,E有两个取代基之一]或其盐或水合物。
  • NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND
    申请人:NAKAMOTO Kazutaka
    公开号:US20110195999A1
    公开(公告)日:2011-08-11
    The present invention provides an antifungal agent represented by the formula: wherein A 1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X 1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A 1 may have 1 to 3 substituents, and E has one or two substituents.
    本发明提供一种抗真菌剂,其化学式如下: 其中,A1代表3-吡啶基,可以有取代基,喹啉基,也可以有取代基等;X1代表由公式—NH—C(═O)—,由公式—C(═O)—NH—等表示的基团;E代表呋喃基,噻吩基,吡咯基,苯基,吡啶基,四唑基,噻唑基或吡唑基;但要求A1可能有1到3个取代基,E有1或2个取代基。
  • Antifungal agent containing heterocyclic compound
    申请人:Eisai R&D Management Co., Ltd.
    公开号:US07932272B2
    公开(公告)日:2011-04-26
    The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].
    本发明提供了一种抗真菌剂,其化学式如下:[其中A1代表3-吡啶基,可以具有取代基,喹啉基,也可以具有取代基等;X1代表由公式—NH—C(═O)—,由公式—C(═O)—NH—等表示的基团;E代表呋喃基,噻吩基,吡咯基,苯基,吡啶基,四唑基,噻唑基或吡唑基;限制条件是A1可以有1到3个取代基,E有一个或两个取代基]。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐